"El Hospital Universitario Quirónsalud Madrid se ha convertido en un referente de la sanidad de la Comunidad de Madrid. Profesionales de primer nivel, alta tecnología y atención personalizada son los tres pilares que sustentan su atención sanitaria. Cuenta con 54.000 metros cuadradados de superficie hospitalaria donde se ofrece atención a 39 especialidades médico-quirúrgicas, lo que lo convierte en un hospital general que es capaz de ofrecer respuesta a todas las necesidades que requieran los pacientes. A sus instalaciones, hay que sumar un Servicio de Urgencias 24 horas."

During the past decade, Hospital Quiron de Madrid; Servicio de Neurologia conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 2 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Quiron de Madrid; Servicio de Neurologia" #1 collaborator was "Prothena Biosciences Limited" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Quiron de Madrid; Servicio de Neurologia" are "Alzheimer Disease" (3 trials), "Multiple Sclerosis" (3 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Alzheimer's Disease" (1 trials) and "Alzheimers Disease" (1 trials). Many other conditions were trialed in "Hospital Quiron de Madrid; Servicio de Neurologia" in a lesser frequency.

Most popular intervention types in "Hospital Quiron de Madrid; Servicio de Neurologia" are "Drug" (11 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (5 trials), "Placebo" (5 trials), "Gantenerumab" (4 trials), "Antihistamine" (2 trials) and "Fenebrutinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Quiron de Madrid; Servicio de Neurologia" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Quiron de Madrid; Servicio de Neurologia". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital Quiron de Madrid; Servicio de Neurologia, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Quiron de Madrid; Servicio de Neurologia, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".